AFLAC Inc. stock rallies 1.40% to $116.29, outperforming competitors

10 articles · Updated · MarketWatch · Apr 28

AFLAC Inc. shares gained for a second consecutive day, closing at $116.29 despite the S&P 500 and Dow Jones both declining.
The stock finished 2.54% below its 52-week high of $119.32, reached on February 5th, and surpassed competitors like Cigna, MetLife, and AIG in Tuesday’s trading.
Trading volume was 1.8 million, notably below the 50-day average of 2.3 million, reflecting subdued investor activity amid a broadly negative market session.

Why does Aflac carry a 'Sell' rating despite its strong stock rally and bullish signals?

With insiders selling shares, should investors worry about Aflac's performance after its earnings call?

Are Aflac's record share buybacks masking underlying weakness in its core Japanese market?

Can Aflac's U.S. growth offset the projected premium decline in its dominant Japan segment?

Does being a 'Most Ethical Company' truly lead to better long-term returns for investors?